RARE Stock News

Headlines · Sentiment · Source Context · AIQ Market Impact

HealthcareBiotechnologyScore data as of Oct 30, 2026

RAREUltragenyx Pharmaceutical Inc.

Healthcare / Biotechnology

Low Priority

In Line With Peers

NeutralEdge 4/10

$16.10−$0.68 (−4.05%)

Latest quote

Momentum
53
Value
50
Quality
64
Risk resilience
22
Sentiment
—

RARE News

Ultragenyx Pharmaceutical Inc. latest headlines and updates

News Sentiment

No recent news found for RARE

News limit reached for Free plan

Upgrade to Pro for full news feed access and deeper AI insights.

Upgrade to Pro

See how news sentiment affects the AIQ Score

Review news alongside the complete analysis workspace.

Related Links

Concepts for this tab

Sentiment Analysis in Markets Earnings Per Share (EPS)Standard Deviation & Volatility

Learn Library

Concepts Guide Diversification Asset Allocation Rebalancing Correlation Position Sizing Risk Budgeting

Explore This Stock

Overview Fundamentals Dividends Technicals Risk Catalysts Financial Data

RARE News FAQ

What is the latest RARE stock news?

The latest RARE stock news appears on this page when current headlines are available. Use news with price movement, sentiment, AIQ Score, and upcoming catalysts.

Why is RARE stock down today?

RARE's daily move can be affected by earnings, guidance, analyst actions, sector news, macro data, or company-specific headlines. Check the current news feed and sentiment before assigning a cause.

What news is affecting RARE stock today?

News affecting RARE today may include earnings updates, price-target changes, product developments, regulatory items, or sector moves. Confirm whether the news is material or just short-term noise.

What should RARE investors watch next?

RARE investors should watch the next earnings update, analyst revisions, material company news, AIQ momentum, and risk changes. Fresh news matters most when it changes estimates or trend quality.